Our Danaher Life Sciences companies support biopharma and service providers in their endeavor to accelerate the CLD process with its comprehensive platform of best-in-class science and technology companies. We recognize the necessity for solutions that eliminate bottlenecks faster and aim to address this with our extensive instrument, software, and services portfolio.
Biopharma Lifecycle Management Software
Digital solutions for bioprocessing that help manage complex datasets
Intabio ZT System
Disruptive approach for characterization of mAb charge variants by imaged capillary isoelectric focusing (icIEF)-UV/MS
ValitaTiter & Assays
Assays that bring complex analytical methods into CLD lab and cut time to data
Cell Line Development Process
One lab, three paths to faster outcomes
LABORATORY AUTOMATION | DIGITAL SOLUTIONS
01 - Vector Construction
The vector construction step of monoclonal antibody (mAb) cell line development requires identifying a gene sequence and assembling it for packaging into a recombinant plasmid. Golden Gate and Gibson assembly are methods of generating recombinant plasmids by ligating small oligos together. Danaher Life Sciences companies provide solutions to support your recombinant plasmid construction.
DIGITAL SOLUTIONS
02 - Sequence Verification
Ensure vectors are ligated correctly and that the sequence of interest is intact, readying vectors for raising a new cell line. Plasmids must undergo DNA sequencing to verify proper gene and vector element sequence after colony picking.
LABORATORY AUTOMATION | DIGITAL SOLUTIONS
03 - Stable Transfection & Selection
Incorporate vectors into genomes, creating new cell lines expressing mAb candidates. Gently recover cells and begin maintaining cultures. Verify that the incorporated insert has not mutated during the transfection and recovery process.
ANALYTICAL TOOLS | DIGITAL SOLUTIONS
04 - Pool Screening
Examine newly raised cell lines for desirable attributes. Screen for product expression, cell viability, and division. Automate subsequent verification and selection steps.
Screening selected pools of cells producing mAbs with required attributes including cell culture maintenance, imaging, and cellular analysis.
LABORATORY AUTOMATION | ANALYTICAL TOOLS | DIGITAL SOLUTIONS
05 - Monoclonality Verification
Verifying that cultures originate from a single cell is a critical regulatory step and eliminates product heterogeneity. Regulatory bodies worldwide require images of cell cultures over time series to ensure cultures derive from a single cell and that products will not be heterogeneous.
LABORATORY AUTOMATION | ANALYTICAL TOOLS | DIGITAL SOLUTIONS
06 - Selection based on Stability/Expansion
Grow and passage cell lines over time. Screen for and document product titer level and cell viability after each round of seeding and growth. Determine the most favorable media conditions and the hardiest clones. Advance with only the most robust cell lines and highest producers.
LABORATORY AUTOMATION | ANALYTICAL TOOLS | DIGITAL SOLUTIONS
07 - Antibody Characterization
Analyze products for most desirable qualities such as structure, glycosylation, binding activity, and stability. Critical quality attributes such as mAb structure, activity, and stability are common targets for analysis.
ANALYTICAL TOOLS | DIGITAL SOLUTIONS
08 - Scale Up: Cell Growth/Expansion
Move cultures from small volumes to bioreactors and gather data on how cell lines tolerate bioreactor stresses and volume scaling. Prioritize developing cultures with best counts and viability over time. Defining optimal processes and cell culture parameters is critical for the tech transfer process and GMP manufacturing.
LABORATORY AUTOMATION | DIGITAL SOLUTIONS
09 - GMP Master Cell Bank
Select final candidates for master cell banking and subsequent process development. Preserve cell lines to create stocks for transfer to a process development laboratory. Cell banks must be preserved at precise time periods, ensuring quality for later stages of drug development.
DIGITAL SOLUTIONS
10 - Data Management
Data capture and proper handling are chief concerns during a drug development workflow. Across workflow steps, the IDBS Polar Biopharma Lifecycle Management platform can tie instruments and workflow processes together with data acquisition and management. Workflow solutions and instrument integrations for end-to-end biopharma lifecycle management make data handling and audit reporting easier.
Software
IDBS Polar
IDBS Polar is the world’s first BioPharma Lifecycle Management (BPLM) platform, eliminating repetitive manual tasks and allowing you to efficiently execute your processes. This enables you to curate the data you need to accelerate time to market by tackling the biggest challenges in process design, optimization, scale-up, and technology transfer.
Back To Top
Products
Beckman Coulter
Echo 525 Acoustic Liquid Handler
Molecular Devices
QPix Microbial Colony Pickers
Beckman Coulter
Biomek i7 Automated Workstation
Beckman Coulter
Biomek NGeniuS Next Generation Library Prep System